Sintx Technologies (SINT) Cash from Financing Activities (2013 - 2026)

Sintx Technologies' (SINT) quarterly Cash from Financing Activities came in at $247000.0 in Q1 2026, down 94.21% year-on-year from $4.3 million in Q1 2025, and down 10.51% quarter-over-quarter from $276000.0 in Q4 2025.

Sintx Technologies (SINT) Cash from Financing Activities (2013 - 2026) Analysis & Trends

Sintx Technologies' Cash from Financing Activities history runs 14 years deep, the most recent figure standing at $247000.0 for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 94.21% year-over-year to $247000.0 in Q1 2026; TTM through Mar 2026 was $4.2 million, a 47.95% decrease from a year earlier, with the FY2025 full-year figure at $8.2 million, down 9.83% from the prior year.
  • Cash from Financing Activities slipped to $247000.0 in Q1 2026 per SINT's latest filing, from $276000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $11.5 million in Q1 2023 and bottomed at -$123000.0 in Q2 2025.
  • The 5-year median for Cash from Financing Activities is $1.0 million (2024), against an average of $2.5 million.
  • Across the five-year window, Cash from Financing Activities jumped 96025.0% in 2022 and plunged 132.8% in 2024, its largest moves.
  • Year by year, Cash from Financing Activities stood at $3.8 million in 2022, then tumbled by 91.91% to $311000.0 in 2023, then plunged by 132.8% to -$102000.0 in 2024, then surged by 370.59% to $276000.0 in 2025, then dropped by 10.51% to $247000.0 in 2026.
  • Per Business Quant, the three latest SINT Cash from Financing Activities figures stand at $247000.0 (Q1 2026), $276000.0 (Q4 2025), and $3.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Sintx Technologies 17,274.80 -1.87 Mn 144,000.00 247,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 247,000.00
Mar 31, 2026 247,000.00
Dec 31, 2025 276,000.00
Dec 31, 2025 276,000.00
Sep 30, 2025 3.78 Mn
Sep 30, 2025 3.78 Mn
Jun 30, 2025 -123,000.00
Jun 30, 2025 -123,000.00
Mar 31, 2025 4.27 Mn
Mar 31, 2025 4.27 Mn
Dec 31, 2024 -102,000.00
Dec 31, 2024 -102,000.00
Sep 30, 2024 2.86 Mn
Sep 30, 2024 2.86 Mn
Jun 30, 2024 1.01 Mn
Jun 30, 2024 1.01 Mn
Mar 31, 2024 5.33 Mn
Mar 31, 2024 5.33 Mn
Dec 31, 2023 311,000.00
Dec 31, 2023 311,000.00